We are live on
!
Find out more
FLXN
Flexion Therapeutics, Inc.
FLXN
FLXN
Delisted
FLXN was delisted on the 18th of November, 2021.
38 hedge funds and large institutions have $110M invested in Flexion Therapeutics, Inc. in 2014 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 13 increasing their positions, 14 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
35% more capital invested
Capital invested by funds: $81.6M → $110M (+$28.4M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
7% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 14
10% less funds holding
Funds holding: 42 → 38 (-4)
50% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 8
Holders
38
Holders Change
-4
Holders Change %
-9.52%
% of All Funds
1.1%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
4
Increased
13
Reduced
14
Closed
8
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Capital World Investors
Los Angeles,
California
|
+$3.32M |
| 2 |
KCM
Kingdon Capital Management
New York
|
+$853K |
| 3 |
Jennison Associates
New York
|
+$581K |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$434K |
| 5 |
GTC
Ghost Tree Capital
New York
|
+$181K |
Top Sellers
| 1 |
JP Morgan Chase
New York
|
-$3.66M |
| 2 |
BC
Broadfin Capital
New York
|
-$724K |
| 3 |
RG
Redmile Group
San Francisco,
California
|
-$552K |
| 4 |
SFM
Soros Fund Management
New York
|
-$405K |
| 5 |
SIM
Spark Investment Management
New York
|
-$136K |
